Skip to content

The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients

Postoperative Outcome After the Application of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Patients Undergoing Major Surgery at the University Hospital of Zurich

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04524260
Enrollment
80
Registered
2020-08-24
Start date
2020-08-31
Completion date
2023-02-28
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Anxiety, Lower Gastrointestinal Neoplasms Benign, Pancreas Cancer, Posttraumatic Stress Disorder

Keywords

painting art therapy, PTSD, alternative/complementary medicine, anxiety

Brief summary

The investigators want to study whether the use of painting art therapy has an influence on the quality of life, the complication rate and the general outcome of major abdominal surgery. The painting art therapy is carried out according to the protocol of (LOM® Solution Centered Art Therapy) by trained painting art therapists.

Detailed description

The interest in alternative and complementary medical treatments has increased significantly in recent years and several studies showed a positive effect on the healing process of patients undergoing surgery. Painting art therapy represents another possible form of such a complementary medical treatment. However, the effect in the context of major abdominal surgical interventions has not yet been investigated, which is why the investigators are conducting this study. Selected patients referred to the Department of Visceral and Transplantation Surgery with operable pathologies of the pancreatic and the lower gastrointestinal tract are subjected to perioperative painting art therapy. It is carried out according to the protocol of (LOM® Solution Centered Art Therapy) by trained painting art therapists. The investigators want to evaluate the effectiveness of perioperative painting art therapy by analyzing the results of several questionnaires regarding anxiety and depression levels as well as health related patient data to observe the short/long term outcome and the psychological well-being of patients undergoing major surgery in case of carcinoma. The aim of the study is to assess if painting art therapy, more precisely the LOM®-method, is effective in reducing symptoms of anxiety and depression in patients undergoing surgery. When it appears that the application of perioperative painting art therapy has a major influence on the postoperative outcome in cancer patients, some patients could benefit from a noninvasive, low-risk and easy additional treatment option. This study is a collaboration with the Institute of Complementary and Integrative medicine of the University Hospital Zurich.

Interventions

BEHAVIORALperioperative painting art therapy (LOM® solution centered art therapy)

We plan to apply painting art therapy as a health-related intervention to patients coming to our department for elective major surgery of the pancreatic and lower gastrointestinal tract for malignant pathologies. Patients will have 3 patient art therapy sessions: one before surgery, one on day 3-5 after surgery during the hospital stay and one during the follow-up 6 weeks postoperative

BEHAVIORALperioperative painting art therapy (LOM® solution centered art therapy) - control

usual care, no particular intervention during the perioperative setting. There will be 2-3 painting art therapy sessions after the follow-up 6 weeks postoperative. Therefore this group is called usual care- or delayed intervention group.

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consecutive adult patients of both genders ≥ 18 years subjected to major (oncological) surgery due to pathologies of the pancreatic and lower gastrointestinal tract at our department. * The initial diagnosis does not date back longer than 6 months prior the planned surgery. Neoadjuvant radio-/chemotherapy is not an

Exclusion criteria

. * Able to speak and understand German or English * Signed written informed consent by the participant after extensive oral and written information about the research project and its aims. * Thresholds of primary outcome: anxiety levels measured with STAI-form Y-1 (state) and Y-2 (trait). Thresholds: scores between 20 (minimum) and 80 (maximum) in each subscore.

Design outcomes

Primary

MeasureTime frameDescription
Change of AnxietyChange from Baseline STAI-Score up to 6 months post surgeryState Trait Anxiety Inventory, STAI-forms Y-1/state and Y-2/trait (questionnaire), scores range from 20 to 80, with higher scores correlating with greater anxiety

Secondary

MeasureTime frameDescription
Change of DepressionChange from Baseline PHQ-9-Score up to 6 months post surgeryPHQ-9 (Brief Patient Health Questionnaire-9), scores ranging from 0 to 27, with higher scores correlating with greater depression
Change of Quality of Life - PROMIS 29Change from Baseline PROMIS 29-Scores up to 6 months post surgeryPROMIS 29 (Profile Physical and Mental Health Summary Scores-questionnaire), scores ranging from 28 to 150, with higher scores correlating with lower quality of life
Change of Health related quality of life - SF-12Change from Baseline SF-12-Scores up to 6 months post surgerySF-12 (short form 12, 12 question survey), results calculated with scoring programme, with higher scores correlating with lower quality of life

Other

MeasureTime frameDescription
Change of Respiratory RateChange from Baseline at 6 months post surgeryRR/min
Laboratory result, chemistry (CRP)Change from Baseline at 6 months post surgeryC-reactive protein (mg/l)
Laboratory result, hematology (Hb)Change from Baseline at 6 months post surgeryHemoglobin, measured in g/l
Laboratory result, hematology (Leucocytes, White Blood Cells)Change from Baseline at 6 months post surgeryWBCs measured in G/l
Complications (Clavien-Dindo-Classification)6 monthsClavien-Dindo-Classification (classified from 0 - V), higher numbers according to more severe complications, V is dead)
Change of Postoperative Pain 1Change from Baseline (NRS pain 0-10) at 6 months post surgerySubjectively perceived (NRS 0-10)
Tumor staging assessed according official TNM-Staging1 week postoperative (as soon as final histopathology is available)TNM-Classification of Malignant Tumors, 8th edition
Socio-economic: days in hospitalup to 6 months post surgeryDays in hospital until discharge, measured in days
Socio-economic: days in ICUup to 6 months post surgeryDays in ICU until discharge to regular unit, measured in days
Socio-economic: ability to return to workup to 6 months post surgeryMeasured will be the time from surgery until return to work, in weeks
Complications (CCI during hospital stay)6 monthsCCI during hospital stay; measured from healthy (0) to death (100)
Change of Postoperative Pain 2Change from Baseline (amount of analgesia) at 6 months post surgeryAmount of Analgesia (data)
Change of Blood pressureChange from Baseline at 6 months post surgerySystolic and diastolic BP in mmHg
Change of Heart RateChange from Baseline at 6 months post surgeryHR in bpm (beats per minute)

Countries

Switzerland

Contacts

Primary ContactEva Breuer, MD
eva.breuer@usz.ch0041 43 253 78 26

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026